Prostate Cancer Clinical Trials
Prostate cancer clinical trials are used to determine just how effective promising new therapies can be. Although they are often thought of as experimental studies, clinical trials are actually conducted after a treatment has been deemed safe. Patients are carefully monitored by physicians and prostate cancer researchers throughout the entire process. Patients are never obligated to participate, and can end their participation at any time.
Clinical trials are not only safe and carefully regulated, but also an important step in determining how a new treatment can best be used to help patients. During a clinical trial, investigators will learn:
- Which doses of the treatment are most effective
- Which patients respond best to the treatment (e.g., patients with a certain stage of cancer, or patients whose tumors are made up of a certain kind of cells)
- Whether the treatment provides the best results on its own or when combined with other therapies
- What side effects might occur, and how they can be managed
As a National Cancer Institute-designed Comprehensive Cancer Center, Moffitt Cancer Center is constantly conducting clinical trials to study the newest treatments for prostate cancer. For instance, we have investigated the role of hormone therapy in patients with rising prostate-specific antigen (PSA) levels after their first attempt at treatment, as well as the effectiveness of bone-strengthening therapies to help reduce the likelihood that prostate cancer will spread to the bones. These are just a small sampling of the trials we’ve conducted; we continually strive to offer our patients more effective treatment options, and our robust clinical trials program is one of the main ways we are able to do so.
To learn more about our prostate cancer clinical trials, call 1-888-663-3488 or complete a new patient registration form. No referral is required; our oncologists will be happy to help you find a trial that may suit your treatment goals.